H.I.G. Capital, an influential global investment firm managing over $65 billion in capital, is reinforcing its presence in the healthcare sector with a series of strategic acquisitions and divestitures. This Miami-based firm is actively reshaping its portfolio to capture growth opportunities across various industries.

In a move that underscores H.I.G. Capital’s commitment to advanced treatments, the firm recently acquired SkinCure Oncology. This company specializes in non-invasive cancer treatments, offering image-guided superficial radiation therapy for nonmelanoma skin cancer. With this acquisition, H.I.G. Capital is set to capitalize on the rising demand for less invasive medical solutions.

Meanwhile, H.I.G. Capital made headlines by selling BIOVECTRA, a contract development and manufacturing organization, to Agilent Technologies for $925 million. This transaction reflects H.I.G. Capital’s ability to nurture businesses to maturity and execute successful exits, enhancing its reputation in the investment community.

Broadening its reach, H.I.G. Capital has also acquired a controlling stake in Naturalia Tantum, an Italian leader in organic and natural beauty products. This venture allows H.I.G. Capital to tap into the fast-growing market for eco-friendly consumer products, aligning with global sustainability trends.

In an adjacent move, H.I.G. Capital ventured into infrastructure support by purchasing Action Elevator. This acquisition, coupled with Action’s purchase of Century Elevator, extends H.I.G. Capital’s services into the Mid-Atlantic region’s elevator maintenance market, which includes vital healthcare facilities.

These strategic moves illustrate H.I.G. Capital’s agile investment approach, targeting sectors poised for growth. By diversifying its portfolio across healthcare, consumer goods, and infrastructure support, H.I.G. Capital continues to strengthen its position as a versatile and forward-thinking investment powerhouse.